Elkind-Hirsch KE, Chappell N, Seidemann E, Storment J, et al. Exenatide, dapagliflozin or phentermine/topiramate differentially affect metabolic profiles in polycystic ovary syndrome. J Clin Endocrinol Metab 2021 Jun 7. pii: 6294193. doi: 10.1210.
PMID: 34097062